D441 Pharmacology Week 3 Practice Quiz 2026 |WGU
1. Which phase of pharmacokinetics is most affected by the first-pass effect?
A. Metabolism
B. Distribution
C. Excretion
D. Absorption
Answer: A
Rationale: The first-pass effect occurs when a drug is metabolized in the liver or intestines
before reaching systemic circulation, which is a process of metabolism.
2. A drug has a high therapeutic index. What does this indicate about the drug’s
safety?
A. The drug is very potent
B. The drug requires frequent blood monitoring
C. The drug has a high risk of toxicity
D. The drug is relatively safe
Answer: D
Rationale: A high therapeutic index means there is a large margin between the effective
dose and the lethal dose, indicating a safer profile.
3. Which protein is the most significant in binding drugs in the bloodstream?
A. Hemoglobin
B. Globulin
C. Fibrinogen
D. Albumin
Answer: D
,Rationale: Albumin is the most common protein in the blood that binds to acidic drugs,
affecting their distribution and free concentration.
4. If a patient has renal failure, which pharmacokinetic process is primarily
impaired?
A. Excretion
B. Absorption
C. Metabolism
D. Distribution
Answer: A
Rationale: The kidneys are the primary organs for drug excretion; renal impairment leads
to drug accumulation due to reduced clearance.
5. A drug with a half-life of 4 hours is administered. How many hours will it take
to reach steady state?
A. 20 hours
B. 12 hours
C. 8 hours
D. 40 hours
Answer: A
Rationale: Steady state is generally reached after 4 to 5 half-lives. 4 hours multiplied by 5
equals 20 hours.
6. What occurs when one drug enhances the effect of another drug beyond the
sum of their individual effects?
A. Antagonism
B. Synergism
C. Tolerance
D. Additive effect
Answer: B
, Rationale: Synergism occurs when the combined effect of two drugs is greater than the
sum of their individual effects (1+1=3).
7. Which route of administration provides 100% bioavailability?
A. Intravenous
B. Oral
C. Intramuscular
D. Subcutaneous
Answer: A
Rationale: Intravenous administration bypasses absorption barriers and first-pass
metabolism, delivering the entire dose directly into the systemic circulation.
8. A patient is taking a drug that is a known enzyme inducer. What is the likely
effect on a second drug metabolized by the same pathway?
A. Increased therapeutic effect
B. No change in effect
C. Increased risk of toxicity
D. Decreased therapeutic effect
Answer: D
Rationale: Enzyme inducers increase the rate of metabolism, leading to faster breakdown
of the second drug and a lower plasma concentration.
9. What is the term for a drug that activates a receptor to produce a biological
response?
A. Antagonist
B. Inhibitor
C. Agonist
D. Blocker
Answer: C
1. Which phase of pharmacokinetics is most affected by the first-pass effect?
A. Metabolism
B. Distribution
C. Excretion
D. Absorption
Answer: A
Rationale: The first-pass effect occurs when a drug is metabolized in the liver or intestines
before reaching systemic circulation, which is a process of metabolism.
2. A drug has a high therapeutic index. What does this indicate about the drug’s
safety?
A. The drug is very potent
B. The drug requires frequent blood monitoring
C. The drug has a high risk of toxicity
D. The drug is relatively safe
Answer: D
Rationale: A high therapeutic index means there is a large margin between the effective
dose and the lethal dose, indicating a safer profile.
3. Which protein is the most significant in binding drugs in the bloodstream?
A. Hemoglobin
B. Globulin
C. Fibrinogen
D. Albumin
Answer: D
,Rationale: Albumin is the most common protein in the blood that binds to acidic drugs,
affecting their distribution and free concentration.
4. If a patient has renal failure, which pharmacokinetic process is primarily
impaired?
A. Excretion
B. Absorption
C. Metabolism
D. Distribution
Answer: A
Rationale: The kidneys are the primary organs for drug excretion; renal impairment leads
to drug accumulation due to reduced clearance.
5. A drug with a half-life of 4 hours is administered. How many hours will it take
to reach steady state?
A. 20 hours
B. 12 hours
C. 8 hours
D. 40 hours
Answer: A
Rationale: Steady state is generally reached after 4 to 5 half-lives. 4 hours multiplied by 5
equals 20 hours.
6. What occurs when one drug enhances the effect of another drug beyond the
sum of their individual effects?
A. Antagonism
B. Synergism
C. Tolerance
D. Additive effect
Answer: B
, Rationale: Synergism occurs when the combined effect of two drugs is greater than the
sum of their individual effects (1+1=3).
7. Which route of administration provides 100% bioavailability?
A. Intravenous
B. Oral
C. Intramuscular
D. Subcutaneous
Answer: A
Rationale: Intravenous administration bypasses absorption barriers and first-pass
metabolism, delivering the entire dose directly into the systemic circulation.
8. A patient is taking a drug that is a known enzyme inducer. What is the likely
effect on a second drug metabolized by the same pathway?
A. Increased therapeutic effect
B. No change in effect
C. Increased risk of toxicity
D. Decreased therapeutic effect
Answer: D
Rationale: Enzyme inducers increase the rate of metabolism, leading to faster breakdown
of the second drug and a lower plasma concentration.
9. What is the term for a drug that activates a receptor to produce a biological
response?
A. Antagonist
B. Inhibitor
C. Agonist
D. Blocker
Answer: C
